Thyrotoxicosis is an essential endocrine topic that each physician must have adequate knowledge. This slide explains the defition of thyrotoxicosis and graves disease as well as the causes, pathogenesis, clinical features and approach.
2. OUTLINE
• THYROID GLAND PHYSIOLOGY
• THYROTOXICOSIS
• GRAVES DISEASE
• CLINICAL FEATURES OF THYROTOXICOSIS AND GRAVES
DISEASE
• INVESTIGATIONS
3. THYROID GLAND PHYSIOLOGY
• Function: responsible for production of thyroid hormones and calcitonin
• THYROID HORMONE SYNTHESIS AND SECRETION
4. REGULATION OF THYROID HORMONES
HYPOTHALAMUS: releases thyrotropin releasing hormone(TRH) and goes to
the anterior pituitary gland.
ANTERIOR PITUITARY GLAND: TRH binds to its receptors of the thyrotropes
and stimulates the synthesis and release of thyroid stimulating hormone(TSH) via
increase of calcium and activation of protein kinase C.
THYROID GLAND: TSH binds to its receptors and stimulates thyroid(T3 and T4)
hormone synthesis via increased cyclic AMP and activation of protein kinase A.
NOTE: WHEN THE LEVELS OF THYROID HORMONES(T3 AND T4)
INCREASES, A NEGATIVE FEEDBACK RESPONSE IS SENT TO THE
HYPOTHALAMUS AND PITUITARY GLAND TO DECREASE THE LEVELS OF
TRH AND TSH.
7. THYROTOXICOSIS
• TERMS:
• Thyrotoxicosis: state of thyroid hormone excess due to any
cause.
• Hyperthyroidism: increased thyroid gland function. One of the
causes of thyrotoxicosis.
• Primary hyperthyroidism: arises from an intrinsic thyroid
abnormality.
• Secondary hyperthyroidism: arises from outside the thyroid
gland.
• NOTE:hyperthyroidism and thyroitoxicosis are words used
interchangeably but are not the same meaning.
10. GRAVES DISEASE
• Described by irish physician Dr Robert graves in 1935.
• Most common cause of thyrotxicosis(accounts 60-80% ofb
thyrotoxicosis)
• Common in females, with F:M ratio of 10:1
• rarely begins before adolescence but occurs between 20 and 50
years of age; also occurs in the elderly.
11. ETIOPATHOGENESIS
• Combination of genetic factors and environmental factors
• 1.) GENETIC FACTORS:
• Polymorphisms in HLA-DR3, CTLA 4, PTPN22, TSH-R gene,FCRL3, and CD226.
• Concordance rate in monozygotic twins is 20-30% compared to that of dizygotic twins
which is <5%.
• 2.) ENVIRONMENTAL FACTORS;
• Pregnancy
• Highly active antiretroviral therapy(HAART)- graves during the immune reconstitution
phase.
• Drugs- lithium, alemtuzumab therapy, iodine, amiodarone
• Infectious disease- yersinia histolytica and other gram negatives containing TSH
binding sites.
• Stress
• Smoking- major risk factor for graves opthalmopathy.
20. • NOTE: In the elderly, features of thyrotoxicosis, may be subtle or
masked and patients may present mainly with fatigue and weight
loss, this condition is known as apathetic thyrotoxicosis.
24. REFERENCES
• DAVIDSONS PRINCIPLES AND PRACTICE OF INTERNAL
MEDICINE(24TH EDITION) BY IAN D, PENMAN, E’TAL..
• HARRISONS PRINCIPLES OF INTERNAL MEDICINE(20TH
EDITION) DR FAUCI, E’TAL..
• KUAMAR AND CLARK’S CLINICAL MEDICINE(10TH EDITION)
BY PROFESSOR DANE PARVEEN J KUMAR, E’TAL.
• BOARD BASICS: AN ENHANCEMENT TO MKSAP 19
• THYROID-PATHOLOGIES-INTRODUCTION-BENIGN-
DISEASE-AND-CARCINOMA-THYROID BY DR. B. SELVARAJ
25. • NEXT SLIDE(PART 02):NEONATAL GRAVES DISEASE,
MANAGEMENT OF THYROTOXICOSIS AND GRAVES.
• THANK YOU..